Regencell Bioscience Holdings (RGC) Cash & Equivalents (2020 - 2026)
Regencell Bioscience Holdings' Cash & Equivalents came in at $14.19 million for the quarter ended Jun 30, 2026, up 486.7% from $2.42 million a year earlier.
Powered by 
Analysis
Regencell Bioscience Holdings (RGC) Cash & Equivalents (2020 - 2026) Analysis & Trends
Going back to the quarter ended Jun 30, 2020, Regencell Bioscience Holdings' Cash & Equivalents data covers 8 quarters.
- Cash & Equivalents carries a five-year compound annual growth rate of 199.0% (years ended Jun 2021 to Jun 2026).
- Going back by year, Cash & Equivalents was $2.42 million in the year ended Jun 30, 2025 (-18.3%), $2.96 million in the year ended Jun 30, 2024 (+89.2%), $1.56 million in the year ended Jun 30, 2023 (-75.6%) and $6.42 million in the year ended Jun 30, 2022.
- The figure for the quarter ended Jun 30, 2026 represents the highest quarterly Cash & Equivalents in data going back to the quarter ended Jun 30, 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Regencell Bioscience Holdings | 3.80 Bn | 3.77 Bn | - | 14.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.19 Mn |
| Dec 31, 2025 | 2.36 Mn |
| Jun 30, 2025 | 2.42 Mn |
| Jun 30, 2024 | 2.96 Mn |
| Jun 30, 2023 | 1.56 Mn |
| Jun 30, 2022 | 6.42 Mn |
| Jun 30, 2021 | 59,413.00 |
| Jun 30, 2020 | 386,979.00 |
API Access
Regencell Bioscience Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "RGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=RGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();